Champions Oncology Inc (STU:2I3)

€ 4 0.1 (2.56%) Market Cap: 55.93 Mil Enterprise Value: 59.94 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 72/100

Q1 2025 Champions Oncology Inc Earnings Call Transcript
Sep 11, 2024

€3.22 (-10.06%)

Earnings
Q4 2024 Champions Oncology Inc Earnings Call Transcript
Jul 18, 2024

€4.38 (+1.39%)

Earnings
Q2 2024 Champions Oncology Inc Earnings Call Transcript
Dec 12, 2023

€4.2 (-4.55%)

Earnings
Q1 2024 Champions Oncology Inc Earnings Call Transcript
Sep 13, 2023

€5.5

Earnings
Q4 2023 Champions Oncology Inc Earnings Call Transcript
Jul 24, 2023

€5.7 (-5.00%)

Earnings
Q3 2023 Champions Oncology Inc Earnings Call Transcript
Mar 16, 2023

€3.74 (-3.11%)

Earnings
Q2 2023 Champions Oncology Inc Earnings Call Transcript
Dec 13, 2022

€5.9 (+0.85%)

Earnings
Q1 2023 Champions Oncology Inc Earnings Call Transcript
Sep 08, 2022

€6.95 (-1.42%)

Earnings
Q4 2022 Champions Oncology Inc Earnings Call Transcript
Jul 21, 2022

€7.6 (-8.98%)

Earnings
Q3 2022 Champions Oncology Inc Earnings Call Transcript
Mar 15, 2022

€6.65 (-4.32%)

Earnings
Q2 2022 Champions Oncology Inc Earnings Call Transcript
Dec 13, 2021

€7 (+0.72%)

Earnings
Q1 2022 Champions Oncology Inc Earnings Call Transcript
Sep 13, 2021

€8.3 (-2.35%)

Earnings
Q4 2021 Champions Oncology Inc Earnings Call Transcript
Jul 22, 2021

€8.35 (+0.60%)

Earnings
Q3 2021 Champions Oncology Inc Earnings Call Transcript
Mar 11, 2021

€8.9 (-6.81%)

Earnings
Q2 2021 Champions Oncology Inc Earnings Call Transcript
Dec 14, 2020

€9.05

Earnings
Q1 2021 Champions Oncology Inc Earnings Call Transcript
Sep 14, 2020

€5.95 (-1.65%)

Earnings
Q4 2020 Champions Oncology Inc Earnings Call Transcript
Jul 27, 2020

€7.7 (-9.41%)

Earnings
Q3 2020 Champions Oncology Inc Earnings Call Transcript
Mar 12, 2020

€4.16 (-2.35%)

Earnings
Q1 2020 Champions Oncology Inc Earnings Call Transcript
Sep 16, 2019

Earnings

Q4 2020 Champions Oncology Inc Earnings Call Transcript

Jul 27, 2020 / NTS GMT

Release Date Price: €7.7 (-9.41%)

Transcript 10-K8-K

Operator

Greetings and welcome to the Champions Oncology fourth-quarter fiscal year 2020 earnings call. (Operator Instructions) Please note that this conference is being recorded.

I would now turn the conference over to our host, Ronnie Morris, Chief Executive Officer of Champions Oncology. Thank you. You may now begin.

Ronnie Morris

Champions Oncology, Inc. - CEO

Good afternoon. I am Ronnie Morris, the CEO of Champions Oncology. I am joined today by David Miller, our CFO. Thank you for joining us for our fiscal year-end 2020 earnings call.

Before I begin, I will remind you that I will be making forward-looking statements during today's call and that actual results could differ materially from what is described in those statements.

Additional information on factors that could cause results to differ is available in our Form 10-Q and Form 10-K. A reconciliation of the non-GAAP financial measures that may be discussed on the call to GAAP financial measures is available in the earnings release.

Overall, we had another year of significant

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.